NeuroMetrix Inc (NURO.OQ) Quote| Reuters.com
Edition:
United States

NeuroMetrix Inc (NURO.OQ)

NURO.OQ on NASDAQ Stock Exchange Capital Market

1.73USD
24 Jun 2016
Change (% chg)

$0.05 (+2.98%)
Prev Close
$1.68
Open
$1.63
Day's High
$1.75
Day's Low
$1.63
Volume
18,962
Avg. Vol
9,553
52-wk High
$4.96
52-wk Low
$1.37

NURO.OQ

Chart for NURO.OQ

About

NeuroMetrix, Inc. (NeuroMetrix) is a health-care company that develops wearable medical technology and point-of-care tests that help patients and physicians manage chronic pain, nerve diseases and sleep disorders. The Company operates through the sale of medical equipment and consumables segment. Its products are sold in the... (more)

Overall

Beta: 0.52
Market Cap(Mil.): $7.59
Shares Outstanding(Mil.): 4.39
Dividend: --
Yield (%): --

Financials

  NURO.OQ Industry Sector
P/E (TTM): -- 46.71 34.11
EPS (TTM): -7.31 -- --
ROI: -150.99 11.65 14.23
ROE: -438.48 13.64 15.46

BRIEF-Neurometrix submits CE Mark application for quell wearable pain relief device

* Neurometrix submits CE Mark application for quell wearable pain relief device Source text for Eikon: Further company coverage: )

Jun 22 2016

BRIEF-Neurometrix announces Quell distribution in Canada

* Neurometrix inc says quell wearable pain relief technology is available in Canada via Amazon Canada Source text for Eikon: (Bengaluru Newsroom; +1 646 223 8780; )

Jun 14 2016

BRIEF-Neurometrix reports Q1 loss per share $1.00

* Neurometrix reports Q1 2016 financial results and highlights

Apr 21 2016

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : ValuEngine, Inc.
$25.00
Provider : S&P Capital IQ Quantitative Report
$92.00
Provider : Pechala's Reports
$25.00
Provider : Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.